Searched for
EFFICACY
Psychology says women who are ready to bargain heavily at any shop aren't frugal or afraid to negotiate: What behavioral research explainsPsychology says women who are ready to bargain heavily at any shop aren't simply trying to save money. Research in psychology and behaviora...- Psychology says people who reread instructions twice before starting something aren’t slow: They’re protecting confidence with clarity, because the mind relaxes when the next step feels certainCountless folks find it beneficial to double-check the instructions prior to embarking on a task. Rather than signaling doubt, this action ...
- Psychology says people who grew up with no close family tend to develop these strengths that only emerge when there’s no safety net underneathGrowing up without a close family can shape individuals profoundly. While challenges in trust and emotional regulation may arise, many deve...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- India to handover $ 2.5 million for development projects in Palestine; reiterates support to two-state solutionIndia has reiterated its support for a negotiated two-state solution to the Israel-Palestine conflict, called for a sustained ceasefire in ...
- Psychology says most young adults learn these 10 brutal truths too late: The last one changes how you see success, happiness, and life foreverAlthough these truths may seem uncomfortable at first, they can be surprisingly liberating. When people let go of the need for perfection, ...
- Psychology says the “cool” parent who lets their child negotiate every boundary is risking one specific outcome, and it usually shows up the moment they enter a professional environmentFor children to flourish, they require a loving touch paired with clear boundaries. Embracing an authoritative parenting style, which blend...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Exploring the legacy of Forever Living ProductsFor nearly five decades, Forever Living Products has established itself as a trusted name in the wellness industry, specializing in aloe ve...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Psychology says people who succeed at almost everything don’t just have luck or a Midas Touch, but these mental traits often do the trickThe psychology behind people who seem to succeed at almost everything suggests their achievements are rarely the result of luck or natural ...
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
Load More
